Associated Papers
Bypassing evolutionary dead ends and switching the rate-limiting step of a human immunotherapeutic enzyme.
Blazeck J et al.
Nature Catalysis, 2022
A high-affinity human PD-1/PD-L2 complex informs avenues for small-molecule immune checkpoint drug discovery.
Tang S et al.
Proceedings of the National Academy of Sciences of the United States of America, 2019
31727844 (PubMed )
Supplement: pnas.1916916116.sapp.pdf
Select a paper to view details